Oct 15, 2026 07:31AM

Oct 15, 2026 07:30AM

Aug 13, 2026 08:30AM

Dec 11, 2025 02:23AM

Dec 2, 2025 07:00AM

Dec 2, 2025 07:00AM

Aug 8, 2025 07:51AM B.Riley Assumes Ovid Therapeutics Inc (OVID) at Buy

Mar 24, 2025 04:55AM

Sep 30, 2024 07:27AM

Sep 26, 2024 08:01AM

Sep 26, 2024 08:00AM

Aug 13, 2024 08:00AM

Aug 6, 2024 04:01PM

Jul 23, 2024 08:00AM Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and Epileptologists

Jul 10, 2024 08:08AM

Jul 10, 2024 08:00AM

Jul 1, 2024 08:02AM

Jul 1, 2024 08:00AM

Jun 18, 2024 04:51AM

Mar 8, 2024 08:00AM

Nov 8, 2022 08:00AM Ovid Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights

Nov 8, 2022 08:00AM

Jun 6, 2022 08:00AM

May 26, 2021 08:19AM

May 26, 2021 08:00AM

Apr 20, 2021 08:00AM

Mar 15, 2021 08:00AM

Mar 3, 2021 09:28AM Pre-Open Stock Movers 03/03: (KMPH) (OVID) (UWMC) Higher; (SSYS) (RKT) (ARNA) Lower (more...)

Dec 2, 2020 09:28AM

Dec 1, 2020 04:53PM

Dec 1, 2020 04:52PM

Nov 23, 2020 04:01PM

Nov 12, 2020 04:10PM

Oct 14, 2020 07:00AM

Oct 12, 2020 07:00AM Ovid Therapeutics to Present at the Child Neurology Society/International Child Neurology Association (CNS/ICNA) Virtual Congress

Sep 30, 2020 08:05AM

Sep 30, 2020 08:00AM

Aug 25, 2020 09:30AM

Aug 10, 2020 08:00AM

Jul 23, 2020 07:00AM

Jul 13, 2020 09:00AM

Jul 13, 2020 07:02AM Ovid Therapeutics (OVID), Angelini Pharma Enter Pact to Develop, Manufacture and Commercialize OV101 for Treatment of Angelman Syndrome in Europe

Jul 13, 2020 07:00AM

Jun 19, 2020 08:03AM

Jun 19, 2020 08:00AM

May 7, 2020 07:48AM

May 7, 2020 07:30AM

Mar 30, 2020 08:00AM

Mar 11, 2020 08:00AM Ovid Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results, Provides Corporate Update for 2020

Jan 7, 2020 08:03AM

335,219 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All